Industry: Pharmaceuticals, Biotechnology
PainCeptor Pharma is a biopharmaceutical company developing next generation therapeutic drugs for the treatment of chronic and acute pain. PainCeptor’s resources are concentrated on some of the most promising, novel, yet scientifically validated therapeutic targets within the PNS (peripheral nervous system). By focusing on modulating target receptors in the PNS, PainCeptor expects to enhance the efficacy and avoid the many detrimental side effects associated with today’s pain drugs which act primarily in the CNS. PainCeptor’s development pipeline includes two lead antagonist programs, targeting NGF/p75-TrkA and ASIC1a, and a third antagonist program targeting ASIC3. ( www.painceptor.com )
PainCeptor Pharma Corp.
7150, Albert-Einstein Suite 100
St-Laurent, Quebec H4S 2C1
Canada
Tel: (514) 337-5959
Fax: (514) 337-8689